Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)
Status: Enrolling
Updated:  9/20/2005
Department Of Veterans Affairs NJ Health Care System
mi
from
East Orange, NJ
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)
Status: Enrolling
Updated: 9/20/2005
Department Of Veterans Affairs NJ Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated:  2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies
Status: Enrolling
Updated: 2/6/2006
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Phase I/II Trial of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  12/17/2007
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Phase I/II Trial of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 12/17/2007
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Status: Enrolling
Updated:  6/3/2008
Kaiser Permanente
mi
from
Vallejo, CA
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Status: Enrolling
Updated: 6/3/2008
Kaiser Permanente
mi
from
Vallejo, CA
Click here to add this to my saved trials
Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery
In Vivo Confocal Endomicroscopy During da Vinci Robot Assisted Prostatectomy: Feasibility Study
Status: Enrolling
Updated:  11/18/2008
The Hospital at Westlake Medical Center
mi
from
Austin, TX
Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery
In Vivo Confocal Endomicroscopy During da Vinci Robot Assisted Prostatectomy: Feasibility Study
Status: Enrolling
Updated: 11/18/2008
The Hospital at Westlake Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Dana-Farber Cancer Institute/Brigham & Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated:  4/27/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Status: Enrolling
Updated: 4/27/2010
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
UCLA
mi
from
Los Angeles, CA
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated:  5/24/2010
Duke Univ Med Ctr
mi
from
Durham, NC
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
Status: Enrolling
Updated: 5/24/2010
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  8/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 8/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated:  9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Cancer Survivors Online Self-Management Workshop
Status: Enrolling
Updated: 9/8/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Trail of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Metastatic Prostate Cancer
A Pilot Phase II Study to Determine the Effects of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Symptomatic and Asymptomatic, Metastatic Prostate Cancer Who Are Chemotherapy-naïve.
Status: Enrolling
Updated:  10/11/2010
Chao Comprehensive Cancer Center
mi
from
Orange, CA
Trail of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Metastatic Prostate Cancer
A Pilot Phase II Study to Determine the Effects of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Symptomatic and Asymptomatic, Metastatic Prostate Cancer Who Are Chemotherapy-naïve.
Status: Enrolling
Updated: 10/11/2010
Chao Comprehensive Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery
Minimally Invasive Urologic Surgery Clip Evaluation: Can We Improve Our Surgical Technique, Reduce Costs and Waste With the Aesculap U-clip Versus the Tele-Flex Hemolock Clip?
Status: Enrolling
Updated:  10/18/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery
Minimally Invasive Urologic Surgery Clip Evaluation: Can We Improve Our Surgical Technique, Reduce Costs and Waste With the Aesculap U-clip Versus the Tele-Flex Hemolock Clip?
Status: Enrolling
Updated: 10/18/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Improving Continence and Quality of Life in Prostate Cancer Patients
Improving Continence and Quality of Life in Prostate Cancer Patients
Status: Enrolling
Updated:  6/1/2011
Case Comprehensive Cancer Center (UHCMC, CCF, MetroHealth)
mi
from
Cleveland, OH
Improving Continence and Quality of Life in Prostate Cancer Patients
Improving Continence and Quality of Life in Prostate Cancer Patients
Status: Enrolling
Updated: 6/1/2011
Case Comprehensive Cancer Center (UHCMC, CCF, MetroHealth)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
A Phase II, Pilot, Randomized, Double-blind Study Comparing the Effectiveness Organic Germanium to Placebo in Decreasing the Severity of Fatigue in Patients Undergoing Radiation Therapy for Prostae and Bbreast Cancers
Status: Enrolling
Updated:  6/21/2011
Arizona Oncology Services
mi
from
Phoenix, AZ
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
A Phase II, Pilot, Randomized, Double-blind Study Comparing the Effectiveness Organic Germanium to Placebo in Decreasing the Severity of Fatigue in Patients Undergoing Radiation Therapy for Prostae and Bbreast Cancers
Status: Enrolling
Updated: 6/21/2011
Arizona Oncology Services
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
University of Chicago Hospitals and Clinics
mi
from
Chicago, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
University of Chicago Hospitals and Clinics
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
Northwestern University Medical Center
mi
from
Chicago, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
Northwestern University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated:  7/20/2011
Onocology Specialists, S.C
mi
from
Niles, IL
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated: 7/20/2011
Onocology Specialists, S.C
mi
from
Niles, IL
Click here to add this to my saved trials
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
Phase I Study Investigating the Safety and Feasibility of Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-Independent Chemotherapy-Failure Prostate Cancer.
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
Phase I Study Investigating the Safety and Feasibility of Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-Independent Chemotherapy-Failure Prostate Cancer.
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
A Phase II Study Evaluating the Toxicity and Efficacy of Single Agent Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen-Independent Prostate Cancer Patients
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
A Phase II Study Evaluating the Toxicity and Efficacy of Single Agent Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen-Independent Prostate Cancer Patients
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
High Risk Prostate Cancer Prevention Study
High Risk Prostate Cancer Prevention Study
Status: Enrolling
Updated:  10/31/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
High Risk Prostate Cancer Prevention Study
High Risk Prostate Cancer Prevention Study
Status: Enrolling
Updated: 10/31/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
High Risk Prostate Cancer Prevention Study
High Risk Prostate Cancer Prevention Study
Status: Enrolling
Updated:  10/31/2011
Veterans Administration Medical Centenr
mi
from
Kansas City, MO
High Risk Prostate Cancer Prevention Study
High Risk Prostate Cancer Prevention Study
Status: Enrolling
Updated: 10/31/2011
Veterans Administration Medical Centenr
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
Status: Enrolling
Updated:  12/1/2011
Division of Urology, Brown University
mi
from
Providence, RI
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
Status: Enrolling
Updated: 12/1/2011
Division of Urology, Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
EMBRACE1: Prostate Biorepository
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
Status: Enrolling
Updated:  1/6/2012
Caris Science, Inc.
mi
from
Phoenix, AZ
EMBRACE1: Prostate Biorepository
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men With Elevated Risk for Prostate Cancer; the EMBRACE1 Study
Status: Enrolling
Updated: 1/6/2012
Caris Science, Inc.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Prospective Study of Changes in Brown Adipose Tissue (BAT) Activity in Men Receiving Androgen Deprivation Therapy (ADT) With a GnRH Agonist or Antagonist for Prostate Cancer
Status: Enrolling
Updated:  1/27/2012
Massachusetts General Hospital
mi
from
Boston, MA
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Prospective Study of Changes in Brown Adipose Tissue (BAT) Activity in Men Receiving Androgen Deprivation Therapy (ADT) With a GnRH Agonist or Antagonist for Prostate Cancer
Status: Enrolling
Updated: 1/27/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
A Pilot Study to Assess the Technical Feasibility of Robotic Assisted Laparoscopic Interpositioning of the AVANCETM Nerve Graft for Reconstruction of the Neurovascular Bundle, With a Twenty-four Month Follow-up Term to Assess Efficacy
Status: Enrolling
Updated:  2/1/2012
Vanderbilt University
mi
from
Nashville, TN
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
A Pilot Study to Assess the Technical Feasibility of Robotic Assisted Laparoscopic Interpositioning of the AVANCETM Nerve Graft for Reconstruction of the Neurovascular Bundle, With a Twenty-four Month Follow-up Term to Assess Efficacy
Status: Enrolling
Updated: 2/1/2012
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Pharmacodynamic Study Using FLT-PET/CT in Patients With Prostate and Other Solid Malignancies Treated With an Interrupted High-dose Axitinib Schedule
Status: Enrolling
Updated:  3/12/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Pharmacodynamic Study Using FLT-PET/CT in Patients With Prostate and Other Solid Malignancies Treated With an Interrupted High-dose Axitinib Schedule
Status: Enrolling
Updated: 3/12/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology Centers of Alabama
mi
from
Homewood, AL
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology Centers of Alabama
mi
from
Homewood, AL
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
South Orange County Urology Research
mi
from
Laguna Hills, CA
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
South Orange County Urology Research
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
San Bernadino Urological Association
mi
from
San Bernadino, CA
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
San Bernadino Urological Association
mi
from
San Bernadino, CA
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
South Florida Medical Research
mi
from
Miami, FL
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
South Florida Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Carolina Clinical Trials
mi
from
Concord, NC
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Carolina Clinical Trials
mi
from
Concord, NC
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology Clinic of North Texas
mi
from
Dallas, TX
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology Clinic of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology San Antonio Research
mi
from
San Antonio, TX
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology-Scottsdale
mi
from
Scottsdale, AZ
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology-Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology - Santa Monica
mi
from
Santa Monica, CA
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology - Santa Monica
mi
from
Santa Monica, CA
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology
mi
from
Cape Coral, FL
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology
mi
from
Cape Coral, FL
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology - Plantation
mi
from
Plantation, FL
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology - Plantation
mi
from
Plantation, FL
Click here to add this to my saved trials
Acceptance-Based Treatment for Prostate Cancer Distress
Pilot Study of an Acceptance and Commitment Therapy Workshop for Distress and Decision Making in Early Stage Prostate Cancer in Veterans
Status: Enrolling
Updated:  5/7/2012
VA San Diego Healthcare System
mi
from
San Diego, CA
Acceptance-Based Treatment for Prostate Cancer Distress
Pilot Study of an Acceptance and Commitment Therapy Workshop for Distress and Decision Making in Early Stage Prostate Cancer in Veterans
Status: Enrolling
Updated: 5/7/2012
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Post-Prostatectomy Erectile Dysfunction: Effect of Hyperbaric Oxygen Therapy
Status: Enrolling
Updated:  5/18/2012
The Hartford Hospital
mi
from
Hartford, CT
Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Post-Prostatectomy Erectile Dysfunction: Effect of Hyperbaric Oxygen Therapy
Status: Enrolling
Updated: 5/18/2012
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/20/2012
University of California, San Francisco
mi
from
San Francisco, CA
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/20/2012
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/20/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/20/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/20/2012
Oregon Health & Science University Cancer Institute
mi
from
Portland, OR
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/20/2012
Oregon Health & Science University Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/20/2012
University of Washington
mi
from
Seattle, WA
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/20/2012
University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials